Author: Customer Service

➢ Approval of a dividend of €7.20 per share, an increase of +2.9%; ➢ Appointment of Mr. Pablo Isla, Ms. Anna Lenz, and Ms. Christel Bories as Directors; ➢ Renewal of the directorships of Mr. Jean-Paul Agon and Mr. Patrice Caine. Following the renewal of his directorship by the Meeting, Mr. Jean-Paul Agon was confirmed as Chairman of the Board of Directors; ➢ Presentations by Mr. Nicolas Hieronimus, CEO, on the Group’s dual financial and non-financial performance and strategy for the coming years, and by Mr. Samuel du Retail, General Manager AI – Data – Shared Services, on the acceleration of Artificial Intelligence. The L’Oréal Annual General Meeting was held today in Paris, under the chairmanship of Mr. Jean-Paul Agon, Chairman of the Board of Directors. Shareholders approved all the resolutions proposed by the Board, and...

TORONTO, April 24, 2026 (GLOBE NEWSWIRE) — Sonor Investments Limited (the “Company” or “Sonor”) (TSX VENTURE:SNI.PR.A) announces its intention to adopt the policies outlined in the Semi-Annual Reporting (“SAR”) Pilot Program utilizing the exemptions provided under Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (the “Blanket Order”). The SAR Pilot Program was implemented under the Blanket Order, which allows an eligible venture issuer to voluntarily move from quarterly to semi-annual financial reporting to ease its regulatory burden. Sonor’s fiscal year ends on December 31. Under the SAR Pilot Program, Sonor will be exempt from filing interim financial reports and related management discussion & analysis (MD&A) for its first quarter-ended March 31 and third quarter-ended...

ST. GALLEN, Switzerland, April 24, 2026 (GLOBE NEWSWIRE) — Sportradar Group AG (Nasdaq: SRAD) (“Sportradar”) today announced it has changed the date of its previously scheduled first quarter earnings call. The Company will now report its financial and operating results for the first quarter of 2026 on April 28, 2026, earlier than the previously announced date of May 6, 2026. Sportradar will also host an earnings call via webcast to discuss the results at 8:00 a.m. Eastern Time on Tuesday, April 28, 2026. Those wishing to either listen to, or participate in, the earnings webcast can do so by accessing Sportradar’s Investor Relations website at https://investors.sportradar.com. Additionally, a replay will be posted on the Investor Relations website for one year after the conclusion of the event. About SportradarSportradar Group AG...

April 24, 2026 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMFDate   Shares   Voting rightsTheoretical* Exercisable**31 March 2026 43,203,225 49,452,796 48,800,292*This number is calculated on the basis of all the shares to which voting rights are attached, including shares which voting rights have been suspended, in accordance with Article 223-11 of the AMF general regulation related to the calculation of the crossing of thresholds with regard to the number of voting rights. **For information purposes, this number excludes the shares which voting rights have been suspended. The information is also available in the « Regulated Information » section of the Ipsos website: https://www.ipsos.com/en/regulated-informations/en....

REGULATORY INFORMATION21 April 2026 Press release Modification of the financial calendar Financial Year 2025/2026 Ascencio announces a change to its financial calendar regarding the publication date of its half-year results for the 2025/2026 financial year. This publication has been brought forward to Monday, May 18, 2026, instead of Wednesday, May 20, 2026. Updated financial calendarHalf-yearly financial report at 31/03/202618/05/2026 (5:40 p.m.) Interim statement at 30/06/202622/07/2026 (5:40 p.m.) Annual press release at 30/09/202625/11/2026 (5:40 p.m.) Ordinary general meeting of shareholders 2025/202629/01/2027 (2:30 p.m.)AttachmentPresse release – Financial Calendar Modification

A collaboration with Virginia Tech supports recognizing remission as a treatment outcome—capturing symptoms, quality of life, and functional outcomes—beyond abstinence alone Of all MOUD, monthly extended-release buprenorphine (BUP-XR) accounted for the smallest proportion of non-fatal and fatal OD events compared to no treatment.RICHMOND, Va., April 24, 2026 (GLOBE NEWSWIRE) — Indivior Pharmaceuticals, Inc. (Nasdaq: INDV), a leader in the treatment of opioid use disorder (OUD), will present one new scientific poster and collaborated with VA Tech on a second poster which will be presented at the American Society of Addiction Medicine (ASAM) Annual Conference, held April 23-26, 2026, in San Diego, California. The data add to the growing body of evidence evaluating extended-release buprenorphine, a monthly injectable commercially...